Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CARRIER STATE”

200 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 200 results

Testing effectiveness (Phase 2)Study completedNCT00458952
What this trial is testing

Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
PheochromocytomaParaganglioma
Molecular Insight Pharmaceuticals, Inc. 24
Not applicableStudy completedNCT00620984
What this trial is testing

Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis

Who this might be right for
MastitisStaphylococcus AureusStaphylococcal Infections
State University of New York - Upstate Medical University 557
Not applicableStudy completedNCT00030134
What this trial is testing

Data Collection in Women With Fabry Disease

Who this might be right for
Fabry Disease
National Institute of Neurological Disorders and Stroke (NINDS) 60
Not applicableStudy completedNCT01712152
What this trial is testing

Myocardial Involvement in Carriers of Duchenne Muscular Dystrophy: An MRI-study

Who this might be right for
Carrier of Duchenne Muscular Dystrophy
Hospital Rudolfstiftung 20
Not applicableWithdrawnNCT01409226
What this trial is testing

3.0 Tesla Magnetic Resonance Imaging for Breast Cancer Detection in High Risk Women

Who this might be right for
Breast CancerBRCA1 MutationBRCA2 Mutation
NYU Langone Health
Not applicableLooking for participantsNCT05474417
What this trial is testing

The Effects of the CF Carrier State on the Kidneys and Pancreas

Who this might be right for
Carrier StatePancreatic DiseaseKidney Diseases
Philip Polgreen 1,250
Not applicableLooking for participantsNCT06431789
What this trial is testing

Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency

Who this might be right for
Gene PolymorphismEdoxabanRenal Insufficiency
Yi Han 220
Not applicableUnknownNCT05110885
What this trial is testing

Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices

Who this might be right for
Spinal Muscular AtrophyDuchenne Muscular DystrophyHealthy Individuals
Bahçeşehir University 200
Testing effectiveness (Phase 2)Looking for participantsNCT04690348
What this trial is testing

Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study

Who this might be right for
Recurrent Brain Metastases
Memorial Sloan Kettering Cancer Center 103
Not applicableUnknownNCT04038905
What this trial is testing

The Use of Digital Genetic Counselor (DGC) for BRCA1/2 Mutation Carrier Testing

Who this might be right for
BRCA Mutations
Igentify Ltd 300
Not applicableUnknownNCT01651559
What this trial is testing

The Efficacy Of A Dead Sea Mineral Enriched Body Cream vs Its Carrier as an Adjuvant Treatment For Psoriatic Patients

Who this might be right for
Psoriasis Vulgaris
Ahava Dead Sea Laboratories 50
Not applicableStudy completedNCT00098800
What this trial is testing

Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierOvarian Cancer
University of Arizona 40
Testing effectiveness (Phase 2)Study completedNCT02314156
What this trial is testing

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Who this might be right for
BRCA1 Mutation CarrierBRCA2 Mutation CarrierDuctal Breast Carcinoma In Situ+6 more
Northwestern University 67
Testing effectiveness (Phase 2)Study completedNCT02337166
What this trial is testing

Regeneration of Human Intrabony Defects With rhFGF-2/HA

Who this might be right for
Periodontitis
Universidade Federal Fluminense 30
Not applicableStudy completedNCT07310641
What this trial is testing

Descriptive Analysis of Preimplantation Genetic Test (PGT)in Couples With Polycystic Kidney Disease (PKD). In the ADPKD Subgroup Evaluation of Outcomes and Complications Comparing Couples in Which the Father is Affected With Couples in Which the Mother is Affected

Who this might be right for
Polycystic Kidney DiseaseAssisted Reproductive TechnologyPreimplantation Genetic Testing (PGT)
Azienda Sanitaria Universitaria Integrata del Trentino 44
Early research (Phase 1)Study completedNCT01730417
What this trial is testing

Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG

Who this might be right for
Neuroendocrine TumorsHeart Failure
Bennett Chin 12
Not applicableUnknownNCT04248504
What this trial is testing

Digital Genetic Assistant (DGA) for Expanded Carrier Screening

Who this might be right for
Genetic Disease
Igentify Ltd 600
Testing effectiveness (Phase 2)Study completedNCT00321633
What this trial is testing

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
University College London Hospitals 148
Not applicableUnknownNCT03965000
What this trial is testing

Human Solute Carrier Family 5 Member 2 (SLC5A2) Deficiency and the Glucagon-Incretin Axis

Who this might be right for
Familial Renal GlucosuriaDiabetes MellitusCardiovascular Diseases
Medical University Innsbruck 10
Early research (Phase 1)Active Not RecruitingNCT02208375
What this trial is testing

MTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian

Who this might be right for
BRCA1 Mutation CarrierBRCA2 Mutation CarrierEndometrial Adenocarcinoma+13 more
M.D. Anderson Cancer Center 159
Load More Results